Concepedia

Hirotetsu Takagi

HT

11

Publications

284

Citations

10

H-Index

1971

Active since

Affiliations

Nara Medical University(Current)

Murata (United States)

Takeda (United States)

Hirotetsu Takagi is an author at Nara Medical University specializing in medicine, liver physiology, and hepatology.

Top concepts

Publications per year

1971–2022

11

Publications

11

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

Koji Ishida, Kosuke Kaji, Shinya Sato et al. · The Journal of Nutritional Biochemistry · 2020 · 84 citations

, , +14

Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease

Kazuki Tahara, Takemi Akahane, Tadashi Namisaki et al. · JGH Open · 2019 · 46 citations · Full text

Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis.

TE Starzl, Graham G. Giles, Lilly et al. · PubMed · 1971 · 32 citations

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects

Hirotetsu Takagi, Kosuke Kaji, Norihisa Nishimura et al. · Cells · 2021 · 27 citations · Full text

, , +18

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis

Hiroyuki Ogawa, Kosuke Kaji, Norihisa Nishimura et al. · Journal of Cellular and Molecular Medicine · 2021 · 18 citations · Full text

Rows per page

1–5 of 11